Валюты / LGND
LGND: Ligand Pharmaceuticals Incorporated
161.71
USD
1.75
(1.09%)
Курс LGND за сегодня изменился на 1.09%. При этом минимальная цена на торгах достигала 160.05, а максимальная — 163.34.
Следите за динамикой Ligand Pharmaceuticals Incorporated. Котировки в реальном времени помогут быстро реагировать на изменения рынка. Переключаясь между различными таймфреймами, можно отслеживать тенденции и динамику курса по минутам, часам, дням, неделям и месяцам. Используйте эту информацию для прогнозирования изменений на рынке и принятия взвешенных торговых решений.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
Новости LGND
- Ligand Pharmaceuticals stock hits 52-week high at 161.93 USD
- Ligand Pharma stock price target raised to $206 from $157 at H.C. Wainwright
- Ligand Pharmaceuticals stock hits 52-week high at $157.54
- Orchestra BioMed stock rating downgraded to Neutral from Buy by BTIG
- Ligand Q1 2025 slides: Revenue surges 46%, strategic Pelthos merger announced
- Ligand Pharmaceuticals completes $460 million convertible notes offering
- Ligand Pharmaceuticals prices $400 million convertible notes offering
- Ligand Pharmaceuticals plans $400 million convertible notes offering
- Ligand Pharma stock price target raised to $185 from $155 at RBC Capital
- Ligand Pharma stock price target raised to $167 by Oppenheimer on strong royalty growth
- Ligand (LGND) Q2 Revenue Jumps 15%
- Ligand Q2 2025 presentation: 57% royalty growth drives raised guidance
- Ligand Pharmaceuticals stock hits 52-week high at 143.31 USD
- Stock Market Week Ahead: Caterpillar, Palantir And Black Hat Week
- Orchestra BioMed secures $70 million from Ligand and Medtronic
- Oppenheimer raises Ligand Pharma stock price target to $162 on royalty growth
- Stifel reiterates Buy rating on Ligand Pharma stock at $143 price target
- Ligand Pharmaceuticals Stock Earns 84 RS Rating
- Ligand Pharmaceuticals stock hits 52-week high at 130.0 USD
- Ligand Pharmaceuticals director Kozarich sells $116k in stock
- Why Is Pelthos Therapeutics Stock Trading Higher Thursday - Pelthos Therapeutics (AMEX:PTHS)
- Ligand earns $5 million milestone as partner launches molluscum treatment
- Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday - First Majestic Silver (NYSE:AG), AES (NYSE:AES)
- Ligand completes merger, Pelthos to launch molluscum treatment
Дневной диапазон
160.05
163.34
Годовой диапазон
93.58
163.34
- Предыдущее закрытие
- 159.96
- Open
- 161.35
- Bid
- 161.71
- Ask
- 162.01
- Low
- 160.05
- High
- 163.34
- Объем
- 301
- Дневное изменение
- 1.09%
- Месячное изменение
- 23.55%
- 6-месячное изменение
- 29.19%
- Годовое изменение
- 52.83%
31 августа, воскресенье